This inventor holds 1 USPTO granted patent. Top assignee: Fondazione Centro San Raffaele Del Monte Tabor. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Massimo Alfano: Innovator in Antibody Research
Introduction
Massimo Alfano is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies. His work focuses on innovative solutions for combating diseases, showcasing his dedication to advancing medical science.
Latest Patents
Massimo Alfano holds a patent for an "Antibody against uPA/uPAR." This invention relates to the anti-HIV action of uPAR-activators or activated uPAR molecules. It also addresses the control of chemotaxis and cell migration by agents that interfere with uPAR activation. Furthermore, the patent outlines a method for determining activated uPAR forms and the use of agents that interfere with uPA/uPAR interaction for the diagnosis or therapy of diseases. This patent highlights his innovative approach to tackling complex health issues.
Career Highlights
Alfano is associated with the Fondazione Centro San Raffaele Del Monte Tabor, where he continues to contribute to groundbreaking research. His work at this esteemed institution underscores his commitment to improving healthcare through scientific innovation.
Collaborations
Massimo Alfano has collaborated with notable colleagues in his field, including Francesco Blasi and Nicolai Sidenius. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Massimo Alfano's contributions to antibody research and his innovative patent demonstrate his significant role in the scientific community. His work not only advances medical knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile